Cliff LedgerPrescription Drug ยท NDA
rx.meruai.co

Eliquis (Apixaban)

Eliquis (Apixaban) by Bristol Myers Squibb: FDA Orange Book core substance LOE 2027-05-21 (last listed 2031-08-24), 2 AB generics, $22.07B 2024 CMS Part D & Medicaid spend, and 12 CA HCAI SB 17 wholesale price filings.

2024 CMS Spend$22.07B
Core LOE Date2027-05-21
AB Generics2
OB Patents4
Source: FDA Orange Book, CMS Part D/Medicaid & CalHHS HCAI SB 17 · Data infrastructure by Meru AIView full dossier on Cliff Ledger (rx.meruai.co) →